JP Morgan 2025: Almirall updates strategy with focus on medical dermatology
Spain's Almirall has announced strategic plans at the 43rd JP Morgan Healthcare Conference based on expected double-digit growth within the…
Pricing and Market Access
Pharma to raise prices on more than 250 drugs in the US from January 2025
Setback for UK pharma as government sets unexpectedly high VPAG payback rate in 2025
Denmark’s HTA evolution
Navigating medicine pricing in Turkiye: the pharmaceutical Euro exchange rate
South Korean pricing reform suggests more flexible drug reimbursement negotiations
Keytruda and Opdivo: a decade review
US negotiations for first round of drugs reveal $6bn in Medicare savings
